This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
Key Sessions
Pam Putz
Welcome and Opening Remarks
EBD Group
Kate Bingham
Top of the pops: Greats of the past, leaders of the future
SV Health Managers
keyboard_arrow_right

Day 1

keyboard_arrow_leftSearch & Filter
search

Day 1

search
07:45 - 09:0075 mins
Main Agenda
Registration and Exhibition Open
    07:45 - 10:30165 mins
    Networking
    Continental Breakfast
      09:00 - 09:4545 mins
      Power - up PartneringONE
      Power up partneringONE: Essentials
      • Lisa Methley - Senior Director, Online Strategy, EBD Group
      09:00 - 10:0060 mins
      Morning Workshop 1
      How to best articulate the strategic value of your assets to potential investors and partners?
      • Ozgur Tuncer - VP Consulting, Strategy Life Science, IQVIA
      • Sofia Ioannidou - Partner, Andera Partners
      • Ankit Pareek - Senior VP, Jefferies
      • Alex Szidon - VP and Head of Business Development, Genentech Research and Early Development, F. Hoffmann-La Roche
      • Karen Wagner - Managing Partner, Ysios Capital Partners
      09:00 - 10:0060 mins
      Morning Workshop 2
      Smart drug discovery
      • Bert Klebl - Managing Director and CSO, Lead Discovery Center
      • Jonas Anielski - Product Life Cycle Manager, Emerging Business Opportunities, Eppendorf
      • Sylvie Bove - Senior Advisor, SmiLe Incubator
      • Thomas Hanke - Head, Academic Partnerships Europe, Evotec
      • Abdelaziz Toumi - Senior Director, Head of Commercial Solutions, Ibex Design & Develop, Lonza
      • Jesús Zurdo - Senior VP Innovation and Venture Partnerships, Rentschler Biopharma
      10:00 - 18:30510 mins
      Partnering
      One-to-one Meetings
        10:45 - 11:1530 mins
        Plenary
        Welcome and Opening Remarks
        • Pam Putz - Managing Director, EBD Group
        • Thilo Rohlfs - State Secretary, Ministry of Economic Affairs, Transport, Employment, Technology and Tourism, Schleswig-Holstein
        • Torsten Sevecke - State Secretary, Ministry of Economy, Transport and Innovation of the Free and Hanseatic City of Hamburg
        • David Thomas - VP, Industry Research, Biotechnology Innovation Organization (BIO)
        11:15 - 11:3015 mins
        Plenary
        Back to the Future: Milestones from the last 25 years
        • Mike Ward - Head of Content Europe, EBD Group and Editor, Europe, Xconomy
        11:30 - 12:3060 mins
        Plenary
        Top of the pops: Greats of the past, leaders of the future
        • Kate Bingham - Managing Partner, SV Health Managers
        • Werner Lanthaler - CEO, Evotec
        • Angeli Moeller - Head IT Business Partnering Research, Bayer
        • Jane Osbourn - Chair, BioIndustry Association (BIA) and Mogrify
        • Paul Stoffels - Vice Chair of the Executive Committee and CSO, Johnson & Johnson
        • Friedrich von Bohlen - CEO, Molecular Health GmbH
        12:00 - 14:00120 mins
        Networking
        Luncheon
          13:30 - 14:3060 mins
          Business Development Track
          Funding trends and how to break them
          • Hubert Birner - Managing Partner, TVM Life Science Management Inc.
          • Sascha Bucher - Head, Global Transactions, Roivant
          • Katie Hewitt - VP, Transactions, Eli Lilly
          • Sean Marett - CBO and CCO, BioNTech
          • Enno Spillner - CFO, Evotec
          13:30 - 14:3060 mins
          Spotlight On
          Evolving priorities in women’s health
          • Lucie Ellis - Executive Editor, In Vivo, Informa Pharma Intelligence
          • Ksenija Pavletic Aranicki - CEO, PregLem SA
          • Patrick Jordan - CEO, Mycovia Pharmaceuticals
          • Mary Kerr - CEO, KaNDy Therapeutics Ltd
          • Sabrina Martucci Johnson - President and CEO, Daré Bioscience, Inc.
          • Karl Ziegelbauer - Senior VP, Open Innovation and Digital Technologies, Bayer AG
          13:30 - 14:3060 mins
          Therapeutic Track
          Immuno-oncology: Optimizing success in the crowded partnering market, and trends for 2020
          • Robert Darwin - Partner, Dechert LLP
          • Shawn Bridy - VP, Business Development, Inovio Pharmaceuticals
          • Annalisa Jenkins - Chair of the Board of Directors, Cell Medica
          • Rainer Kramer - CBO and Managing Director, Immatics
          • Brendan Luu - VP, Head, Oncology Business Development, Merck KGaA
          • Guillaume Vignon - Senior VP Business Development, BeiGene Switzerland GmbH
          13:30 - 17:30240 mins
          Presentations
          Pharma Presentations
            14:45 - 15:4560 mins
            Business Development Track
            The China market: Valuable opportunities, sophisticated business models, novel science
            • Ruediger Herrmann - Partner, McDermott, Will & Emery
            • Ming Fang - Global Head Business Development, Elpiscience
            • Vivian Feng - Senior Director Business Development, Fosun Pharma
            • Ji Li - Venture Partner, Lilly Asia Ventures
            • James Huang - Managing Partner, Panacea Venture
            • Jonathan Wang - VP & Head of BD, Zai Lab
            14:45 - 16:1590 mins
            Spotlight On
            CNS Company Presentations
              14:45 - 15:4560 mins
              Therapeutic Track
              Immuno-Oncology Company Presentations
                15:00 - 16:0060 mins
                Power - up PartneringONE
                Power up partneringONE: Experienced
                • Lisa Methley - Senior Director, Online Strategy, EBD Group
                15:00 - 17:00120 mins
                Let's talk...series
                Let's talk...CARDIOLOGY
                • Lucie Carrier - Professor of Functional Genomics of Cardiomyopathies, Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf
                • Thomas Eschenhagen - Director, Institute of Experimental Pharmacology and Toxicology, University Medical Centre Hamburg-Eppendorf; Chairman, German Centre for Cardiovascular Research (DZHK)
                • Robert Fischer - CEO, OMEICOS
                • Berthold Hinzen - VP and Head BD&L,Therapeutic Areas, Bayer AG
                • Johannes Holzmeister - Chairman and CEO, DiNAQOR
                • Philip Larsen - Senior VP, Global Head, Research, Bayer
                • Alexander Meyer - Physician and Computer Scientist, German Center of Cardiovascular Research (DZHK)
                • Andreas Scheel - EVP Cell Therapy, Evotec
                • Frank Schoening - Senior VP, Global Head, Strategic Marketing Cardiovascular, Bayer
                • Frans Wuite - CEO, Acesion Pharma
                16:00 - 17:0060 mins
                Business Development Track
                Emerging pharma first launch and partnering
                • Ben Hohn - Principal, BD, Pipeline and Launch Strategy, ZS Associates
                • Joe Dupere - CEO, Rexgenero Ltd
                • Andrew Hotchkiss - CCO, Immunocore
                16:00 - 17:0060 mins
                Therapeutic Track
                Workable business models for AMR innovation
                • Sandra Wirsching - Director Business Development and Managing Editor, BIOCOM AG
                • Michel de Baar - Executive Director, Business Development, Europe, MSD
                • Yann Ferrisse - Head of Business Development, Global Antibiotic R&D Partnership (GARDP)
                • Cyrille Kuhn - Head of Research Beyond Borders US, Boehringer Ingelheim
                • Diego Tonelli - Investment Economist, European Investment Bank
                • Holger Zimmermann - CEO, AiCuris Anti-infective Cures
                16:05 - 16:2520 mins
                Extra Activity
                Break and Breathe
                  16:15 - 17:1560 mins
                  Spotlight On
                  How to cope: Transversing the neuro path
                  • Mike Ward - Head of Content Europe, EBD Group and Editor, Europe, Xconomy
                  • John Isaac - Senior Director, External Scientific Innovation, Neuroscience, Johnson & Johnson Innovation
                  • Jill Richardson - Senior Director, MSD
                  • Lesley Stolz - Executive VP and CBO, Annexon Biosciences
                  • Marie Trad - VP, Therapeutic Area Head, CNS Division, IQVIA Biotech
                  16:35 - 16:5520 mins
                  Extra Activity
                  Break and Breathe
                    17:15 - 18:0045 mins
                    Business Development Track
                    Dealmaking in the microbiome field: The coming of age
                    • Eric de La Fortelle - Managing Director, Health Opportunities GmbH
                    • Gil Bar-Nahum - Managing Director, Jefferies
                    • Rodolphe Clerval - CBO, Enterome
                    • Jean-Christophe Hyvert - CCO, LPBN, Lonza Pharma and Biotech
                    • Isabelle de Cremoux - CEO and Managing Partner, Seventure
                    • Jonathan Solomon - CEO, BiomX
                    17:15 - 18:1560 mins
                    Therapeutic Track
                    Infectious Disease Company Presentations
                      18:00 - 18:4545 mins
                      Networking
                      Champagne reception at EBD Group booth #161
                        19:00 - 22:00180 mins
                        Networking
                        Evening Networking Reception with Buffet-style Dinner
                          PRE-EVENT Program
                          NextDay 2

                          Get the latest news.
                          As it happens

                          Sign up to get the latest on the agenda and speakers.
                          Filter
                          Streams
                          Formats
                          Choose Day